4.0
Jan 14, 2016
Anonymous employee
Former employee
Recommend
CEO approval
Business outlook
Pros
One of Novartis' division. Small structure in France (150 people). Good ambiance.
Cons
Less innovation because of the nature of the business: generic drugs